Hepatology
Video
Obeticholic acid reversed NASH liver fibrosis in phase 3 trial
VIENNA – Phase 3 trial results showed obeticholic acid, already FDA approved, is the first drug to reverse liver fibrosis in NASH patients.
Conference Coverage
Future of NASH care means multiple targets, multiple providers, expert says
PHILADELPHIA – While current options are limited, newer treatments targeting different aspects of NASH pathogenesis could improve long-term...
From the Journals
For patients with HBV, daily aspirin may reduce risk of liver cancer
Sixteen years of data showed that daily aspirin therapy reduced the risk of HBV-related hepatocellular carcinoma by 29%.
Video
DDNA19: Cardiac Complications in Liver Disease Patients
Dr. Marc Klapholz explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic...
From the Journals
One-time, universal hepatitis C testing cost effective, researchers say
Compared with birth cohort screening alone, universal one-time screening for hepatitis C was cost effective as long as the prevalence of chronic...
From the Journals
Women survive more often than men do when hospitalized with cirrhosis
Women more often had infections and comorbidities, while men more often had liver decompensation, which contributed most significantly to their...
From the Journals
Perceptions of liver transplantation for ALD are evolving
Liver transplantation for alcohol-associated liver disease is occurring earlier and more frequently than before.
Latest News
Risk-based testing missed 35% of HCV-positive prison inmates
From the Journals
Biomarker algorithm may offer noninvasive look at liver fibrosis
Algorithm distinguished NAFLD patients with advanced liver fibrosis from those with mild to moderate fibrosis.
Conference Coverage
It’s time for universal HCV screening in the ED
SAN FRANCISCO –
From the Journals
AVERT: Apixaban reduced thromboembolism risk in cancer patients
Cancer patients treated with apixaban had a significantly lower rate of venous thromboembolism but a higher risk of major bleeds than did those...